People
-
Former SkyePharma CEO and current Executive Chairman of PolyTherics Ken Cunningham has joined the Board of Directors of inhaled drug developer Prosonix as a Non-Executive Director. Cunningham will also serve as Chair of the Prosonix… Read more . . .
-
Shortly after announcing positive Phase 2a results for its glycopyrrolate inhalation solution, Elevation Pharmaceuticals, announced that it has appointed Jaisim Shah as Senior Vice President and Chief Business Officer and Pravin Soni as Senior Vice… Read more . . .
-
Team Consulting has hired David Harris, inventor of the Conix dry powder inhaler, which was licensed to 3M Drug Delivery Systems in 2008 by his then employer, Cambridge Consultants. In 2009, Harris joined Sagentia, where… Read more . . .
-
MAP Pharmaceuticals has hired Frederick H. Graff as VP, Commercial Operations, a position newly created in anticipation of a potential launch of the company’s Levadex inhaled dihydroergotamine (DHE) for the treatment of migraine. Graff was… Read more . . .
-
Jim Nightingale has been promoted from Senior VP for Business Development and Strategic Alliances to President of drug development company Bend Research. Rod Ray is stepping down as President but will remain as CEO and… Read more . . .
-
Inhaled antibiotic developer Insmed has hired Andrea (“Andi”) Holtzman Drucker as its Senior Vice President, General Counsel and Corporate Secretary, which is a newly-created position reporting directly to Insmed President and CEO Timothy Whitten. Drucker… Read more . . .
-
Pulmatrix, which recently launched its new iSperse dry powder delivery system, has announced the promotion of Robert Clarke to Chief Scientific Officer (CSO) and VP of Research and Development. In addition, the company has added… Read more . . .
-
University of Melbourne spin-off Otifex has reportedly raised $1.1 million for the development of a nasal spray to treat otitis media with effusion (OTE), in which viscous fluid builds up in the middle ear, potentially… Read more . . .
-
Canadian biotech company Asmacure has announced that Martin Driscoll will replace Luc Vachon as Chief Executive Officer. Vachon is leaving the company “to pursue other business ventures.” Asmacure is developing an inhaled nictonic receptor agonist,… Read more . . .
-
Activaero has hired Christian Pangratz as its new Chief Business Officer, replacing Henrik Luessen. Pangratz comes to Activaero from Nektar, where he served as Executive Director of Business Development. Luessen will continue to work with… Read more . . .
Featured event:

Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden
October 21-October 22: MVIC Symposium, Lund, Sweden
October 28-October 30: Deutches Aerosol Therapie Symposium (DATS), Marburg, Germany
November 10-November 11: Rescon Europe 2026, Porto, Portugal



